US approval for Pharmaxis asthma test October 9, 2010
Posted by admin in : Asthma, Research/Studies/Education , comments closedTweet from AdvanceRespCare
Pharmaceutical company Pharmaxis (ASX:PXS) is pleased to announce the US Food and Drug Administration (FDA) has approved AridolTM (mannitol inhalation powder) Bronchial Challenge Test Kit for marketing.
Pharmaxis Acting Chief Executive Officer Mr Gary Phillips said, “We are extremely pleased with this achievement. An FDA submission is a complex task requiring involvement from almost all divisions of the company and this positive outcome has shown Pharmaxis’ ability to successfully work with the FDA to achieve a positive outcome.
Clearance Received By Covidien For Its Puritan Bennett 840 Ventilator System August 10, 2009
Posted by admin in : Featured Articles, News , comments closedMedical News Today News Article: ”
Clearance Received By Covidien For Its Puritan Bennett 840 Ventilator System
08 Aug 2009
Covidien (NYSE: COV), a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Leak Compensation software feature for the Puritan Bennett 840™ ventilator system. This option provides continuous levels of mechanical ventilation to patients requiring respiratory support, regardless of the level of gas leakage that might occur in the circuit or past a patient interface device in the clinical setting.
During either invasive or noninvasive ventilation, air leaks past a mask, nasal prongs, nasal pillow, supraglottic airway, endotracheal tube or tracheostomy tube can result in loss of gas volume, potentially causing subsequent dysynchrony between a patient’s spontaneous breathing efforts and the ventilator’s response.
The ”
(Via Medical News Today News Article
.)